Children’s of Alabama Completes 150+ Sedation-Free TNEs With the EvoEndo Endoscopy System
EvoEndo®, Inc. (EvoEndo) announces that Children’s of Alabama has now completed over 150 Sedation-Free Transnasal Endoscopies (TNE) using the EvoEndo® Single-Use Endoscopy System. Children’s of Alabama is the first provider in the region to bring this innovative technology to their patients five and older.
Hackensack Meridian Children’s Health Joseph M. Sanzari Children’s Hospital Leads the Way in New Jersey, Becoming the First to Offer Sedation-Free TNE with the EvoEndo Endoscopy System
EvoEndo®, Inc. (EvoEndo) announces that Joseph M. Sanzari Children’s Hospital is the first provider in New Jersey to bring Sedation-Free Transnasal Endoscopy (TNE) of the Upper Gastrointestinal Tract to patients aged five and older using the EvoEndo® Single-Use Endoscopy System.
Recent Research Supports Sedation-Free TNE for Effective Management of GI Disorders Utilizing the EvoEndo System
Recently published scientific abstracts and peer-reviewed papers support the efficacy and demand for gastroenterology programs to offer Sedation-Free Transnasal Endoscopy (TNE) utilizing the EvoEndo System as an alternative to traditional TNE. Findings suggest a valuable opportunity to optimize the patient experience, minimize risks associated with anesthesia, and improve diagnostic outcomes.
EvoEndo Announces Investment from AGA’s GI Opportunity Fund
EvoEndo®, Inc. (“EvoEndo”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), announced that the company received an investment from the American Gastroenterological Association's (AGA) new venture capital fund, GI Opportunity Fund 1.
